News · Europe CBD
The Netherlands sells CBD oils openly, but THC enforcement is tighter than Germany's 0.3% total THC line. Domestic oils are commonly held near 0.05% THC. Full-spectrum bottles that pass in Berlin often fail Dutch expectations.
CBD itself is not listed as a narcotic in the Dutch Opium Act (Opiumwet). Delta-9 THC is List I; cannabis flowers and resin are List II. Legal risk sits in THC content and product format, not in CBD alone.
Unlike Germany’s single 0.3% total THC reference (including THCA), the Netherlands does not publish one statutory percentage for every CBD product. In practice, authorities commonly apply about 0.05% THC to CBD oils manufactured or packaged in the Netherlands. Oils legally produced in other EU member states are often tolerated closer to 0.2% on import – enforcement practice, not a courtroom guarantee.
Ingestible CBD still sits under Regulation (EU) 2015/2283 on novel foods. The NVWA treats unauthorised ingestible CBD as non-compliant even when shops stock it. EFSA’s provisional safe intake for high-purity CBD (about 2 mg/day for a 70 kg adult) is a risk-assessment reference, not a Novel Food authorisation.
Cross-border EU shopping makes the gap concrete. Germany aligned hemp products to 0.3% total THC. Dutch oil enforcement stays stricter for home-made and home-packed products. If you live in the Netherlands or ship there, do not copy a German full-spectrum SKU without reading the lab line for total THC.
Disclaimer: This is news context for shoppers, not legal or medical advice. Dutch Opiumwet and NVWA practice can change. Check current official guidance before you buy, ship or sell CBD products.
Domestic Dutch oils are commonly held near 0.05% THC. EU-imported oils from other member states are often tolerated closer to 0.2% if legally produced abroad. Always verify on the batch COA.
No. CBD flowers are treated as cannabis under the Opiumwet and remain the highest-risk format despite retail CBD oils being widely sold.
No. EFSA's provisional intake is a risk-assessment reference for high-purity CBD supplements, not a Novel Food authorisation.
News
Slovakia removed cannabidiol from its national narcotics list with effect from 1 May 2021, but this did not create a blanket exemption from EU product rules. For ingestible…
The EU Scientific Committee on Consumer Safety finalised advice on CBD in cosmetics on 26 March 2026 and published it on 24 April. Pure CBD is considered safe…
Austria is more open on low-THC hemp flowers than Portugal or Greece, yet 2025 tobacco-monopoly practice pushed dried flowers toward licensed tobacconists. AGES still blocks cannabinoid oils and…
On 9 February 2026 the Commission terminated the procedure for cannabidiol from Cannabis sativa L. (NF/2022/11411) without adding it to the Union list of novel foods. Incomplete dossiers…
Medical Disclaimer
The information on this website is for general informational purposes only and does not constitute medical advice. CBD products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before using CBD, especially if you are pregnant, nursing, taking medication, or have a medical condition.
CBD legality varies by country and region. In the EU, CBD products containing less than 0.2% THC are generally permitted, but local laws may differ. Verify the legal status in your jurisdiction before purchasing or using CBD products.
This website may contain affiliate links. We may earn a commission from qualifying purchases at no additional cost to you. Affiliate relationships do not influence our editorial content or product recommendations.
Last updated: August 2026
